Literature DB >> 8604629

Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation.

A P Fitzpatrick1, H D Kourouyan, A Siu, R J Lee, M D Lesh, L M Epstein, J C Griffin, M M Scheinman.   

Abstract

One hundred seven patients underwent atrioventricular (AV)-junctional ablation and pacing for atrial fibrillation, and 90 were alive 2.3 +/- 1.2 years later. Quality of life index (1.9 +/- 1.2 to 3.6 +/- 1.1; 3.6 +/- 1.1; p<0.001) and ease of activities of daily living (2 +/- 0.4 to 2.4 +/- 0.3; p<0.001) were significantly improved. Doctor visits (10 +/- 13 to 5.06 +/-7; p<0.03), hospital admissions (2.8 +/- 6.8 vs 0.17 +/- 0.54; p<0.03, and antiarrhythmic drug trials (6.2 +/- 4 to 0.46 +/- 1.5; p<0.001) decreased significantly after treatment. Congestive heart failure episodes decreased from 18 before to 8 afterward. Twenty-eight of 36 patients with dual-chamber pacemakers remained in a dual-chamber mode at follow-up. Radiofrequency AV-junctional catheter ablation and pacing is a highly successful form of treatment for medically refractory atrial fibrillation.

Entities:  

Mesh:

Year:  1996        PMID: 8604629     DOI: 10.1016/s0002-8703(96)90528-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  36 in total

Review 1.  Science, medicine, and the future: Radiofrequency ablation for atrial fibrillation.

Authors:  N R Grubb; S Furniss
Journal:  BMJ       Date:  2001-03-31

Review 2.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

Review 3.  The ablate-and-pace strategy in atrial fibrillation.

Authors:  P O'Callaghan
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

Review 4.  Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Authors:  I Savelieva; A J Camm
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

Review 5.  [Catheter ablation and implantable atrial defibrillators in supraventricular cardiac arrhythmias].

Authors:  W Jung; B Schumacher; B Lüderitz
Journal:  Med Klin (Munich)       Date:  1997-04-15

6.  Supraventricular Tachyarrhythmia.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-08

Review 7.  Computational approaches to structural and functional analysis of plastocyanin and other blue copper proteins.

Authors:  F De Rienzo; R R Gabdoulline; R C Wade; M Sola; M C Menziani
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

8.  Rate control in atrial fibrillation: what approach is best?

Authors:  Brian Olshansky
Journal:  Curr Cardiol Rep       Date:  2004-09       Impact factor: 2.931

Review 9.  Quality of life in atrial fibrillation.

Authors:  B Lüderitz; W Jung
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

10.  Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.

Authors:  Osmar Antonio Centurión; Karina Elizabeth Scavenius; Laura B García; Luis Miño; Judith Torales; Orlando Sequeira
Journal:  J Atr Fibrillation       Date:  2018-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.